Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism PRKDC inhibitors(DNA-dependent protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma of Head and Neck | Preclinical | New Zealand | 01 Jan 2024 |